4570 · Immuno-Biological Laboratories Co., Ltd. · Financials
Market Cap
8.54B JPY
Shares
9.31M
Volume · Nov 13
78.7K
Avg daily vol (3M)
127.51K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
1B
+3.7%
FY2026
Net Income
329.02M
+32.1%
FY2026
Gross Margin
70.35%
+4.9pp
FY2026
Operating Margin
27.99%
+6.4pp
FY2026
Operating Cash Flow
301.09M
+64.1%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| JPY | 1B | 969.53M | 816.7M | 794.62M | 647.58M | 602.75M |
| JPY | 297.97M | 335.07M | 299.41M | 267.91M | 270.88M | 255.89M |
| JPY | 707.01M | 634.46M | 517.29M | 526.71M | 376.7M | 346.86M |
| JPY | 281.28M | 209.35M | 104.3M | 58.37M | -122.22M | -240.98M |
| JPY | 300.56M | 209.86M | 124.64M | -280.61M | -250.14M | -310.63M |
| JPY | -28.45M | -39.19M | -62.05M | 9.12M | 8.63M | 8.2M |
| JPY | 329.02M | 249.05M | 186.69M | -289.73M | -258.77M | -318.83M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.